COMP <GO>
ACRS vs NGNE // EV/EBITDA & P/E VALUATION
Aclaris Therapeutics Inc. (NASDAQ) VS. Neurogene Inc. (NASDAQ) • 15-METRIC TALLY: ACRS 3
— NGNE 2
■ METRIC PARITY
LAST: $3.99 (+0.76%) • MKT CAP: $587.3M
valuation
—
LAST: $28.82 (-5.26%) • MKT CAP: $576.7M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACRS VS. NGNE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACRS | NGNE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 73.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.04% | -13.59% | +5.55 | ACRS | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -58.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 12.76 | -12.56 | NGNE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | ACRS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.5 | 51.0 | -5.46 | NGNE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $587.3M | $576.7M | $10.6M | ACRS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACRS REV | NGNE REV | ACRS GROSS % | NGNE GROSS % | ACRS FCF | NGNE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $7.8M | $0 | 73.3% | — | -$47.2M | -$78.4M |
| FY 2024 | $18.7M | $925.0K | 85.1% | — | -$20.2M | -$71.4M |
| FY 2023 | $31.2M | $0 | — | — | -$78.3M | -$51.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACRS // BETA —
NGNE // BETA —